The U.S. Food and Drug Administration (FDA) has granted Faxitron Bioptics 510(k) clearance for the company's LOCalizer wireless radiofrequency identification (RFID) system for localizing breast lesions too small to be felt.
The system allows surgeons to measure distance to a target lesion more accurately during breast surgery, according to Faxitron.
